Education and launch updates are open — clinical enrollment follows verified readiness
Chapter 9Lesson 35 of 52 7 minute read

What GLP-1 Medications Can—and Cannot—Do

Place medication inside a whole-person treatment and monitoring plan.

Whole for Good editorial teamUpdated July 16, 2026Sources listed below

What to know

FDA-approved GLP-1–based medications have specific indications and prescribing information.

Response, tolerability, contraindications, access, and preferences vary.

Medication does not replace adequate nutrition, strength, sleep, or clinical follow-up.

This week’s practice

Turn the lesson into one useful experiment.

  1. 1

    Write what you hope medication would change.

  2. 2

    List prior weight treatments, conditions, and relevant symptoms.

  3. 3

    Prepare questions about benefits, risks, alternatives, cost, and follow-up.

Questions to take into care

Am I an appropriate candidate for an FDA-approved option?

How will benefit and tolerability be evaluated?

Safety note

This lesson does not determine eligibility or recommend a medication.

Why this chapter matters

Medication and GLP-1 Literacy

Anti-obesity medications are clinical tools, not stand-alone curricula. Eligibility, product selection, titration, monitoring, contraindications, side effects, access, and continuation require individualized clinician oversight.

Your Academy progress

Finished this lesson?

Progress is saved privately on this device. Sign in to sync it to your account.

Next: GLP-1 Side-Effect Preparation

Sources and editorial status

Prepared from authoritative public-health, regulatory, and professional guidance. This educational page is not individualized medical advice. Final clinical approval is required before it is used as patient-specific guidance.